Fen-Phen, Redux and Pondimin information
Legal Issues
Medical Issues
About S&W
Contact Us
Kava Liver Lawsuit
Joseph H. Saunders
is designated a Board Certified Civil Trial Lawyer by The Florida Bar
Fen-Phen, Redux and Pondimin information
  location: home > legal Fen-Phen, Redux and Pondimin information
There have been two medical conditions associated with the use of these diet drugs. Pulmonary hypertension and heart valvular dysfunction.


The August 26, 1996 publication of The New England Journal of Medicine reported the results of the International Primary Pulmonary Hypertension study (FN4 html) entitled "Appetite Suppressants and the Risk of Primary Pulmonary Hypertension." This study concluded that fen-phen and other fenfluramine-based diet drugs increased the risk of Pulmonary Hypertension by a multiple of more than thirty (30) times normal. The manufacturers and distributors of these diet drugs were aware of the results of the International Primary Pulmonary Hypertension study by at least November of 1995, but did not warn the public or the physicians of the risk of contracting Pulmonary Hypertension. Pulmonary Hypertension is a serious disorder which is often fatal. The only known cure is a lung transplant or heart and lung transplant.


The Mayo Clinic in Rochester, Minnesota released an emergency report on July 8, 1997 (FN5 html) linking the use of phentermine and fenfluramine to unusual, potentially life-threatening, valvular dysfunction and blood regurgitation in twenty-four (24) women. The report observed that cardiovascular testing procedures, principally the electrocardiogram and echocardiogram procedures, revealed that each of twenty-four (24) patients had one or more heart valves that were thickened and that blood was regurgitating, or leaking backwards, making the heart work harder to pump blood throughout the body. The Mayo Clinic report also observed that eight of the patients had newly documented pulmonary hypertension. Cardiac surgical intervention, to replace bad valves, was required in five of the twenty-four (24) patients as of July 8, 1997. The emergency release of the Mayo Clinic study, well in advance of its scheduled publication in The New England Journal of Medicine, appears to have been motivated by the extraordinary incidence of life threatening valvular heart disease and pulmonary hypertension in persons taking the diet drugs phentermine, fenfluramine and dexfenfluramine.


What Are These Diet Drugs? :
The combination use of Fenfluramine and phentermine and with dexfenfluramine is not approved by the United States Food and Drug Administration (FDA), but was not illegal when these drugs were on the market. Doctors are generally permitted to make "off-label" or non-approved uses of drugs if the drugs are approved for any use.

Symptoms Of Injury From Fen-Phen, Redux Or Pondimin Use:
Usually the first symptom of injury from these diet drugs is shortness of breath. Medically shortness of breath is called dyspnea


home· legal issues · medical issues · about S&W · contact us

All contents copyright © 2010 Last Edited March 20 2010
Saunders & Walker, P.A.
3491 Gandy Blvd N. Suite 200 Pinellas Park, Florida 33781
Phone: (727) 579-4500 Fax: (727) 577-9696 Email: info@saunderslawyers.com